Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11766463 Microorganisms engineered to reduce hyperphenylalaninemia

Patent 11766463 was granted and assigned to Synlogic on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

James Spoonamore

Adam Lawrence

Per Greisen

Kristin Adolfsen

Isolde Callihan

Jay Konieczka

Date of Patent

September 26, 2023

Patent Application Number

17832487

Date Filed

June 3, 2022

Patent Citations

US Patent 10294499 Biosynthesis of phenylpropanoids and phenylpropanoid derivatives

US Patent 10610546 Bacteria engineered to reduce hyperphenylalaninemia

US Patent 11060073 Bacteria engineered to treat diseases associated with hyperammonemia

US Patent 10883115 Protein kinase polynucleotides and polypeptides for increasing abiotic stress tolerance, yield, biomass, growth rate, and/or vigor in a plant

US Patent 7731976 Treatment of irritable bowel syndrome using probiotic composition

US Patent 9688967 Bacteria engineered to treat diseases associated with hyperammonemia

US Patent 9889164 Bacteria engineered to treat a disease or disorder

US Patent 9943555 Bacteria engineered to reduce hyperphenylalaninemia

...

Patent Primary Examiner

Patent abstract

Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating diseases associated with hyperphenylalaninemia are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11766463 Microorganisms engineered to reduce hyperphenylalaninemia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool